SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-181696
Filing Date
2022-06-27
Accepted
2022-06-24 17:48:32
Documents
13
Period of Report
2022-06-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d387575d8k.htm   iXBRL 8-K 33225
2 EX-99.1 d387575dex991.htm EX-99.1 210398
  Complete submission text file 0001193125-22-181696.txt   409696

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20220624.xsd EX-101.SCH 2894
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20220624_lab.xml EX-101.LAB 17996
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20220624_pre.xml EX-101.PRE 11287
7 EXTRACTED XBRL INSTANCE DOCUMENT d387575d8k_htm.xml XML 3335
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 221041153
SIC: 2834 Pharmaceutical Preparations